Butyrate Inhibits Cancerous HCT116 Colon Cell Proliferation but to a Lesser Extent in Noncancerous NCM460 Colon Cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Butyrate Inhibits Cancerous HCT116 Colon Cell Proliferation but to a Lesser Extent in Noncancerous NCM460 Colon Cells
Authors
Keywords
-
Journal
Nutrients
Volume 9, Issue 1, Pages 25
Publisher
MDPI AG
Online
2017-01-02
DOI
10.3390/nu9010025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual Role of p21 in the Progression of Cancer and Its Treatment
- (2016) Amna Parveen et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage
- (2016) Ansar Karimian et al. DNA REPAIR
- Vimentin, colon cancer progression and resistance to butyrate and other HDACis
- (2016) Darina L. Lazarova et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Indole-3-carbinol induces tumor cell death: function follows form
- (2016) Bryant W. Megna et al. JOURNAL OF SURGICAL RESEARCH
- The microbiome and its potential as a cancer preventive intervention
- (2016) Scott J. Bultman SEMINARS IN ONCOLOGY
- Colorectal cancer development and advances in screening
- (2016) Vanessa Balchen et al. Clinical Interventions in Aging
- Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis
- (2015) Yu Sun et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate
- (2014) Sabita N. Saldanha et al. EXPERIMENTAL CELL RESEARCH
- Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention
- (2014) Huawei Zeng World Journal of Gastrointestinal Oncology
- Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study
- (2013) Tim G. de Meij et al. INTERNATIONAL JOURNAL OF CANCER
- Cyclin-dependent kinase inhibitor p21Waf1: Contemporary view on its role in senescence and oncogenesis
- (2012) V. S. Romanov et al. BIOCHEMISTRY-MOSCOW
- Butyrate
- (2012) Alda J. Leonel et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- The Inhibitor of Histone Deacetylases Sodium Butyrate Enhances the Cytotoxicity of Mitomycin C
- (2012) A. Gospodinov et al. MOLECULAR CANCER THERAPEUTICS
- Dietary Regulation of Histone Acetylases and Deacetylases for the Prevention of Metabolic Diseases
- (2012) Tho Pham et al. Nutrients
- cMyc Is a Principal Upstream Driver of β-Cell Proliferation in Rat Insulinoma Cell Lines and Is an Effective Mediator of Human β-Cell Replication
- (2011) Esra Karslioglu et al. MOLECULAR ENDOCRINOLOGY
- Secondary necrosis: The natural outcome of the complete apoptotic program
- (2010) Manuel T. Silva FEBS LETTERS
- Activation of the AMP activated protein kinase by short-chain fatty acids is the main mechanism underlying the beneficial effect of a high fiber diet on the metabolic syndrome
- (2009) Guo-Xin Hu et al. MEDICAL HYPOTHESES
- Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter
- (2008) H. Nian et al. CARCINOGENESIS
- Natural products and colon cancer: current status and future prospects
- (2008) Subapriya Rajamanickam et al. DRUG DEVELOPMENT RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now